Crossmark

Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success

Crossref DOI link: https://doi.org/10.1007/s00417-017-3836-1

Published Online: 2017-10-29

Published Print: 2018-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Laiginhas, Rita

Silva, Marta Inês

Rosas, Vitor

Penas, Susana

Fernandes, Vitor Adriano

Rocha-Sousa, Amândio

Carneiro, Ângela

Falcão-Reis, Fernando

Falcão, Manuel Sousa
License Information

License valid from 2017-10-29